The DOI matches its Crossref record; 150 of the 150 references it cites were found in a registry or an index.
Drug transport to brain with targeted nanoparticles
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biodegradable polymeric nanoparticles as drug delivery devices
Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00339-4 · Cited by 3,549
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,361
Biodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V., Torchilin, V., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,920
Biodegradation and biocompatibility of PLA and PLGA microspheres
Anderson, J. M., & Shive, M. S. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00048-3 · Cited by 2,617
Gref, R., Lück, M., Quellec, P., Marchand, M., Dellacherie, E., Harnisch, S., Blunk, T., & Müller, R. H. (2000) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00156-3 · Cited by 1,723
Chemistry for peptide and protein PEGylation
Roberts, M. J., Bentley, M. D., & Harris, J. M. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00022-4 · Cited by 1,604
Solid lipid nanoparticles for parenteral drug delivery
Wissing, S. A., Kayser, O., & Müller, R. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.12.002 · Cited by 1,495
Moghimi, S. M., & Szebeni, J. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00033-x · Cited by 1,227
Nanoparticulate systems for brain delivery of drugs.
Kreuter, J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00122-8 · Cited by 1,107 · cited 2×
“incubation in citrate-stabilized plasma at 37°C, but not on nanoparticles coated with poloxamers 338, 407, Cremophor EL, or RH 40.(29) Despite numerous arguments listed by Kreuter,(29) this hypothesis raises questions, based on the following observations.”
BackgroundPanyam, J., Zhou, W., Prabha, S., Sahoo, S. K., & Labhasetwar, V. (2002) · The FASEB Journal · doi:10.1096/fj.02-0088com · Cited by 1,044
Govender, T. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00116-3 · Cited by 1,008
Sahoo, S. K., Panyam, J., Prabha, S., & Labhasetwar, V. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00127-x · Cited by 990
Nanoparticulate systems for brain delivery of drugs
Kreuter, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.015 · Cited by 958
The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres
Gref, R., Domb, A., Quellec, P., Blunk, T., Müller, R. H., Verbavatz, J. M., & Langer, R. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00026-4 · Cited by 820
Protein Instability in Poly(Lactic-co-Glycolic Acid) Microparticles
van de Weert, M., Hennink, W. E., & Jiskoot, W. (2000) · Pharmaceutical Research · doi:10.1023/a:1026498209874 · Cited by 708
Li, S. (1999) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(1999)48:3<342::aid-jbm20>3.0.co;2-7 · Cited by 664
Brain drug delivery of small molecules using immunoliposomes
Huwyler, J., Wu, D., & Pardridge, W. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14164 · Cited by 656
Stealth Me. PEG‐PLA Nanoparticles Avoid Uptake by the Mononuclear Phagocytes System
Bazile, D., Prud'homme, C., Bassoullet, M., Marlard, M., Spenlehauer, G., & Veillard, M. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600840420 · Cited by 635
Folate receptor targeted biodegradable polymeric doxorubicin micelles
Yoo, H. S., & Park, T. G. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.02.003 · Cited by 620
Nanoparticle Technology for Drug Delivery Across the Blood-Brain Barrier
Lockman, P. R., Mumper, R. J., Khan, M. A., & Allen, D. D. (2002) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120001481 · Cited by 592 · cited 1×
“Based on general parenteral formulation considerations and specific BBB features, Table 1 summarizes the ideal nanoparticle properties required for drug brain delivery.(4) One particularly”
BackgroundSize-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles
Prabha, S., Zhou, W.-Z., Panyam, J., & Labhasetwar, V. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00315-0 · Cited by 553
PEGylated PLGA nanoparticles as protein carriers: Synthesis, preparation and biodistribution in rats
Li, Y.-P., Pei, Y.-Y., Zhang, X.-Y., Gu, Z.-H., Zhou, Z.-H., Yuan, W.-F., Zhou, J.-J., Zhu, J.-H., & Gao, X.-J. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00218-8 · Cited by 540 · cited 2×
“based on the [(water-in-oil)-in water] solvent evaporation technique.(75,104,105) Entrapment efficiencies generally range from 10% to 90%,(75,104,106) and nanoparticle contents from 1% or less(99,107,108) to more than 15%.”
BackgroundPassage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles)
Kreuter, J., Alyautdin, R. N., Kharkevich, D. A., & Ivanov, A. A. (1995) · Brain Research · doi:10.1016/0006-8993(95)00023-j · Cited by 539
Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA–PEG block copolymer
Yoo, H. S., & Park, T. G. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00340-0 · Cited by 538
Zambaux, M. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00106-5 · Cited by 537
Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications
Vauthier, C., Dubernet, C., Fattal, E., Pinto-Alphandary, H., & Couvreur, P. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(03)00041-3 · Cited by 527
Characterization of nanoparticle uptake by endothelial cells
Davda, J., & Labhasetwar, V. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00923-1 · Cited by 524
Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles
Gulyaev, A. E., Gelperina, S. E., Skidan, I. N., Antropov, A. S., Kivman, G. Y., & Kreuter, J. (1999) · Pharmaceutical Research · doi:10.1023/a:1018983904537 · Cited by 521
Dong, Y., & Feng, S.-S. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2003.09.055 · Cited by 468
Long-circulating pegylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery.
Calvo, P., Gouritin, B., Chacun, H., Desmaële, D., D'Angelo, J., Noel, J.-P., Georgin, D., Fattal, E., Andreux, J. P., & Couvreur, P. (2001) · Pharmaceutical Research · doi:10.1023/a:1010931127745 · Cited by 443
Yamamoto, Y., Nagasaki, Y., Kato, Y., Sugiyama, Y., & Kataoka, K. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00451-5 · Cited by 442
Chemotherapy of glioblastoma in rats using doxorubicin‐loaded nanoparticles
Steiniger, S. C. J., Kreuter, J., Khalansky, A. S., Skidan, I. N., Bobruskin, A. I., Smirnova, Z. S., Severin, S. E., Uhl, R., Kock, M., Geiger, K. D., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20048 · Cited by 434
Stealth PLA-PEG nanoparticles as protein carriers for nasal administration
Tobío, M., Gref, R., Sánchez, A., Langer, R., & Alonso, M. J. (1998) · Pharmaceutical Research · doi:10.1023/a:1011922819926 · Cited by 402
Peracchia, M. T., Fattal, E., Desmaële, D., Besnard, M., Noël, J. P., Gomis, J. M., Appel, M., d’Angelo, J., & Couvreur, P. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00063-2 · Cited by 400
Alyautdin, R. N., Petrov, V. E., Langer, K., Berthold, A., Kharkevich, D. A., & Kreuter, J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012098005098 · Cited by 352
Mosqueira, V. C. F., Legrand, P., Gulik, A., Bourdon, O., Gref, R., Labarre, D., & Barratt, G. (2001) · Biomaterials · doi:10.1016/s0142-9612(01)00043-6 · Cited by 325
Doxorubicin-conjugated biodegradable polymeric micelles having acid-cleavable linkages
Yoo, H. S., Lee, E. A., & Park, T. G. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00088-3 · Cited by 324
Panyam, J., Williams, D., Dash, A., Leslie‐Pelecky, D., & Labhasetwar, V. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20094 · Cited by 320
Hagan, S. A., Coombes, A. G. A., Garnett, M. C., Dunn, S. E., Davies, M. C., Illum, L., Davis, S. S., Harding, S. E., Purkiss, S., & Gellert, P. R. (1996) · Langmuir · doi:10.1021/la950649v · Cited by 319
Perez, C., Sanchez, A., Putnam, D., Ting, D., Langer, R., & Alonso, M. J. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00397-2 · Cited by 313
Nanoparticles of Biodegradable Polymers for Clinical Administration of Paclitaxel
Feng, S.-S., Mu, L., Win, K., & Huang, G. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043455909 · Cited by 311
Riley, T., Stolnik, S., Heald, C. R., Xiong, C. D., Garnett, M. C., Illum, L., Davis, S. S., Purkiss, S. C., Barlow, R. J., & Gellert, P. R. (2001) · Langmuir · doi:10.1021/la001226i · Cited by 306
Pharmacokinetics and distribution of a biodegradable drug-carrier
Grislain, L., Couvreur, P., Lenaerts, V., Roland, M., Deprez-Decampeneere, D., & Speiser, P. (1983) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(83)90166-7 · Cited by 305
Stolnik, S., Dunn, S. E., Garnett, M. C., Davies, M. C., Coombes, A. G. A., Taylor, D. C., Irving, M. P., Purkiss, S. C., Tadros, T. F., Davis, S. S., et al. (1994) · Pharmaceutical Research · doi:10.1023/a:1018931820564 · Cited by 292
Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles
Konan, Y. N., Gurny, R., & Allémann, E. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00944-9 · Cited by 279
Brain-specific expression of an exogenous gene after i.v. administration
Shi, N., Zhang, Y., Zhu, C., Boado, R. J., & Pardridge, W. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221450098 · Cited by 273
Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres
Blanco, M. D., & Alonso, M. J. (1997) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00056-8 · Cited by 269
Peracchia, M. T., Gref, R., Minamitake, Y., Domb, A., Lotan, N., & Langer, R. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(96)01597-0 · Cited by 266
Noninvasive gene targeting to the brain
Shi, N., & Pardridge, W. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.130187497 · Cited by 252
Elamanchili, P., Diwan, M., Cao, M., & Samuel, J. (2004) · Vaccine · doi:10.1016/j.vaccine.2003.12.032 · Cited by 246
Brain Drug Targeting: The Future of Brain Drug Development
Pardridge, W. M. (2001) · Cambridge University Press eBooks · doi:10.1017/cbo9780511549571 · Cited by 246
Recent Advances in the Stabilization of Proteins Encapsulated in Injectable PLGA Delivery Systems
Schwendeman, S. P. (2002) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v19.i1.20 · Cited by 235
Alyautdin, R. N., Tezikov, E. B., Ramge, P., Kharkevich, D. A., Begley, D. J., & Kreuter, J. (1998) · Journal of Microencapsulation · doi:10.3109/02652049809006836 · Cited by 229
Defining the drug incorporation properties of PLA–PEG nanoparticles
Govender, T. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00375-6 · Cited by 225
Lemoine, D., Francois, C., Kedzierewicz, F., Preat, V., Hoffman, M., & Maincent, P. (1996) · Biomaterials · doi:10.1016/0142-9612(96)00049-x · Cited by 219
Colloidal stability and drug incorporation aspects of micellar-like PLA–PEG nanoparticles
Riley, T., Govender, T., Stolnik, S., Xiong, C. D., Garnett, M. C., Illum, L., & Davis, S. S. (1999) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00066-1 · Cited by 219
Lee, J., Cho, E. C., & Cho, K. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.10.012 · Cited by 218
Synthesis of Pegylated Immunonanoparticles
Olivier, J.-C., Huertas, R., Lee, H. J., Calon, F., & Pardridge, W. M. (2002) · Pharmaceutical Research · doi:10.1023/a:1019842024814 · Cited by 217
Self-citationOlivier, J.-C., Fenart, L., Chauvet, R., Pariat, C., Cecchelli, R., & Couet, W. (1999) · Pharmaceutical Research · doi:10.1023/a:1018947208597 · Cited by 213
Self-citationAllémann, E., Leroux, J.-C., Gurny, R., & Doelker, E. (1993) · Pharmaceutical Research · doi:10.1023/a:1018970030327 · Cited by 212
Bazile, D. V., Ropert, C., Huve, P., Verrecchia, T., Mariard, M., Frydman, A., Veillard, M., & Spenlehauer, G. (1992) · Biomaterials · doi:10.1016/0142-9612(92)90142-b · Cited by 200
Preparation and characterization of protein C-loaded PLA nanoparticles
Zambaux, M. F., Bonneaux, F., Gref, R., Dellacherie, E., & Vigneron, C. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00073-5 · Cited by 200
Nanocapsules: A new type of lysosomotropic carrier
Couvreur, P., Tulkenst, P., Roland, M., Trouet, A., & Speiser, P. (1977) · FEBS Letters · doi:10.1016/0014-5793(77)80717-5 · Cited by 197
Surface-engineered nanoparticles for multiple ligand coupling
Gref, R., Couvreur, P., Barratt, G., & Mysiakine, E. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00348-x · Cited by 197
Kreuter, J., Petrov, V. E., Kharkevich, D. A., & Alyautdin, R. N. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00061-8 · Cited by 196
Pardridge, W. M., Boado, R. J., & Kang, Y. S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5592 · Cited by 195
Vittaz, M., Bazile, D., Spenlehauer, G., Verrecchia, T., Veillard, M., Puisieux, F., & Labarre, D. (1996) · Biomaterials · doi:10.1016/0142-9612(95)00322-3 · Cited by 193
Heald, C. R., Stolnik, S., Kujawinski, K. S., De Matteis, C., Garnett, M. C., Illum, L., Davis, S. S., Purkiss, S. C., Barlow, R. J., & Gellert, P. R. (2002) · Langmuir · doi:10.1021/la011393y · Cited by 192
Verrecchia, T., Spenlehauer, G., Bazile, D. V., Murry-Brelier, A., Archimbaud, Y., & Veillard, M. (1995) · Journal of Controlled Release · doi:10.1016/0168-3659(95)00053-b · Cited by 189
Morlock, M., Koll, H., Winter, G., & Kissel, T. (1997) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(96)00017-3 · Cited by 188
Sah, H. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00148-5 · Cited by 187
Polyhydroxyalkanonate derivatives in current clinical applications and trials
Ueda, H., & Tabata, Y. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(03)00037-1 · Cited by 187
Kawashima, Y., Yamamoto, H., Takeuchi, H., Hino, T., & Niwa, T. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00121-5 · Cited by 181
Biodegradation and brain tissue reaction to poly(D,L-lactide-co-glycolide) microspheres
Menei, P., Daniel, V, Montero-Menei, C., Brouillard, M., Pouplard-Barthelaix, A., & Benoit, J. P. (1993) · Biomaterials · doi:10.1016/0142-9612(93)90151-q · Cited by 180
Global non-viral gene transfer to the primate brain following intravenous administration
Zhang, Y., Schlachetzki, F., & Pardridge, W. M. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(02)00018-7 · Cited by 178
Manuela Gaspar, M., Blanco, D., Cruz, M. E. M., & José Alonso, M. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00196-x · Cited by 175
Something new in the field of PLA/GA bioresorbable polymers?
Vert, M., Schwach, G., Engel, R., & Coudane, J. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00240-x · Cited by 173
Quellec, P., Gref, R., Perrin, L., Dellacherie, E., Sommer, F., Verbavatz, J., & Alonso, M. J. (1998) · Journal of Biomedical Materials Research · Cited by 167
Alyaudtin, R. N., Reichel, A., Löbenberg, R., Ramge, P., Kreuter, J., & Begley, D. J. (2001) · Journal of Drug Targeting · doi:10.3109/10611860108997929 · Cited by 166
Biodegradable micro- and nanoparticles as long-term delivery vehicles for interferon-alpha
Sánchez, A., Tobı́o, M., González, L., Fabra, A., & Alonso, M. J. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(03)00019-8 · Cited by 162
Lherm, C., Müller, R. H., Puisieux, F., & Couvreur, P. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90210-s · Cited by 159
Investigation of polymeric nanoparticles as carriers of enalaprilat for oral administration
Grabnar, P. A., Kristl, J., Kristl, A., & Vrečer, F. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00076-5 · Cited by 157
Jaeghere, F. D., Allémann, É., Leroux, J., Stevels, W. M., Feijén, J., Doelker, É., & Gurny, R. (1999) · Pharmaceutical Research · doi:10.1023/a:1018826103261 · Cited by 155
Kattan, J. G., Droz, J., Couvreur, P., Marino, J. P., Boutan-Laroze, A., Rougier, P. R., Brault, P., Vranckx, H., Grognet, J., Morge, X., et al. (1992) · Investigational New Drugs · doi:10.1007/bf00877245 · Cited by 153
Brain Drug Targeting: The Future of Brain Drug Development
Pardridge, W. M. (2001) · Cited by 150
Critical Determinants in PLGA/PLA Nanoparticle-Mediated Gene Expression
Prabha, S., & Labhasetwar, V. D. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016250.56402.99 · Cited by 150
Gbadamosi, J. K., Hunter, A. C., & Moghimi, S. M. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03710-9 · Cited by 150
Alyautdin, R. N., Gothier, D., Петров, Kharkevich, D. A., & Kreuter, J. (1995) · European Journal of Pharmaceutics and Biopharmaceutics · Cited by 148
Péan, J., Boury, F., Venier‐Julienne, M., Meneï, P., Proust, J. E., & Benoît, J. (1999) · Pharmaceutical Research · doi:10.1023/a:1014818118224 · Cited by 147
Friese, A. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(99)00073-9 · Cited by 139
Safety of Poly(ethylene glycol) and Poly(ethylene glycol) Derivatives
Working, P. K., Newman, M. S., Johnson, J. A., & Cornacoff, J. B. (1997) · ACS symposium series · doi:10.1021/bk-1997-0680.ch004 · Cited by 139
Horisawa, E., Hirota, T., Kawazoe, S., Yamada, J., Yamamoto, H., Takeuchi, H., & Kawashimà, Y. (2002) · Pharmaceutical Research · doi:10.1023/a:1015123024113 · Cited by 138
In vitro model for the degradation of alkylcyanoacrylate nanoparticles
Müller, R. H., Lherm, C., Herbert, J., & Couvreur, P. (1990) · Biomaterials · doi:10.1016/0142-9612(90)90084-4 · Cited by 138
Matsumoto, J., Nakada, Y., Sakurai, K., Nakamura, T., & Takahashi, Y. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00153-2 · Cited by 137 · cited 2×
“In most studies, in vitro release profiles are characterized by an initial fast release (burst) of drug close to or at the surface followed by a sustained release.(91,92,103) Removing the low molecular weight fraction from the polymer was shown to reduce the initial burst of drug release.”
BackgroundReceptor‐mediated delivery of an antisense gene to human brain cancer cells
Zhang, Y., Lee, H. J., Boado, R. J., & Pardridge, W. M. (2002) · The Journal of Gene Medicine · doi:10.1002/jgm.255 · Cited by 132
A Novel Reactive Polymeric Micelle with Aldehyde Groups on Its Surface
Scholz, C., Iijima, M., Nagasaki, Y., & Kataoka, K. (1995) · Macromolecules · doi:10.1021/ma00125a040 · Cited by 126
Preparation and characterization of propranolol hydrochloride nanoparticles: a comparative study
Ubrich, N., Bouillot, P., Pellerin, C., Hoffman, M., & Maincent, P. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.03.023 · Cited by 125
Niwa, T., Takeuchi, H., Hino, T., Kunou, N., & Kawashimà, Y. (1994) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600830527 · Cited by 122
Toxicity of Polyalkylcyanoacrylate Nanoparticles I: Free Nanoparticles
Kante, B., Couvreur, P., Dubois-Krack, G., de Meester, C., Guiot, P., Roland, M., Mercier, M., & Speiseru, P. (1982) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600710716 · Cited by 121
Drug delivery using biodegradable microspheres
Okada, H., Masaki, Y., Heya, T., Inoue, Y., Shigeru, K., Ogawa, Y., & Toguchi, H. (1994) · Journal of Controlled Release · doi:10.1016/0168-3659(94)90159-7 · Cited by 120
Gref, R., Quellec, P., Sánchez, A., Calvo, P., Dellacherie, E., & Alonso, M. J. (2001) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00143-0 · Cited by 115
Tissue distribution of doxorubicin associated with polyisohexylcyanoacrylate nanoparticles
Verdun, C., Brasseur, F., Vranckx, H., Couvreur, P., & Roland, M. (1990) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf02940287 · Cited by 115
Leo, E., Brina, B., Forni, F., & Vandelli, M. A. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.03.002 · Cited by 111
Löbenberg, R. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00105-3 · Cited by 109 · cited 1×
“and not at all typical of drugs associated to nonstealth colloidal drug carriers.(21,22,23,36) Therefore, as an alternative to the brain uptake of nanoparticles, we hypothe-”
BackgroundMoghimi, S. M. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00204-5 · Cited by 103
Protein Delivery from Biodegradable Microspheres
Cleland, J. L. (2005) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-46803-4_1 · Cited by 102
Allémann, É., Gravel, P., Leroux, J., Balant, L., & Gurny, R. (1997) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(199711)37:2<229::aid-jbm12>3.0.co;2-9 · Cited by 94
Hoffart, V., Ubrich, N., Simonin, C., Babak, V. G., Vigneron, C., Hoffman, M., Lecompte, T., & Maincent, P. (2002) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120014576 · Cited by 94
Péan, J., Meneï, P., Morel, O., Montero‐Menei, C. N., & Benoît, J. (2000) · Biomaterials · doi:10.1016/s0142-9612(00)00141-1 · Cited by 93
Nanoparticulate delivery system of a tyrphostin for the treatment of restenosis
Fishbein, I., Chorny, M., Rabinovich, L., Banai, S., Gati, I., & Golomb, G. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00244-8 · Cited by 89
Biocompatibility of Poly (DL-Lactide-co-Glycolide) Microspheres Implanted into the Brain
Emerich, D. F., Tracy, M. A., Ward, K. L., Figueiredo, M., Qian, R., Henschel, C., & Bartus, R. T. (1999) · Cell Transplantation · doi:10.1177/096368979900800114 · Cited by 85
Biodistribution of poly(butyl 2-cyanoacrylate) nanoparticles in rabbits
Douglas, S. J., Davis, S. S., & Illum, L. (1986) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(86)90021-9 · Cited by 84
Salem, A. K., Cannizzaro, S. M., Davies, M. C., Tendler, S. J. B., Roberts, C. J., Williams, P. M., & Shakesheff, K. M. (2001) · Biomacromolecules · doi:10.1021/bm010030+ · Cited by 84
Stolnik, S., Heald, C. R., Neal, J. C., Garnett, M. C., Davis, S. S., Illum, L., Purkiss, S. C., Barlow, R. J., & Gellert, P. R. (2001) · Journal of drug targeting · doi:10.3109/10611860108998772 · Cited by 82
Quellec, P., Gref, R., Dellacherie, E., Sommer, F., Tran, M. D., & Alonso, M. J. (1999) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(19991205)47:3<388::aid-jbm14>3.0.co;2-v · Cited by 79
Ray, A. L., Vert, M., Gautier, J. C., & Benoît, J. (1994) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)90003-5 · Cited by 74
Yamamoto, Y., Nagasaki, Y., Kato, M., & Kataoka, K. (1999) · Colloids and Surfaces B Biointerfaces · doi:10.1016/s0927-7765(99)00065-x · Cited by 72
Azmin, M. N., Stuart, J. F. B., & Florence, A. T. (1985) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00258124 · Cited by 69
Müller, R. H., Lherm, C., Herbort, J., Blunk, T., & Couvreur, P. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90209-k · Cited by 69
Amine-Reactive Biodegradable Diblock Copolymers
Teßmar, J., Mikos, A. G., & Göpferich, A. M. (2001) · Biomacromolecules · doi:10.1021/bm015608u · Cited by 69
Labhasetwar, V. D., Bonadio, J. F., Goldstein, S. A., & Levy, R. J. (1999) · Colloids and Surfaces B Biointerfaces · doi:10.1016/s0927-7765(99)00079-x · Cited by 67
Design of triptorelin loaded nanospheres for transdermal iontophoretic administration
Nicoli, S., Santi, P., Couvreur, P., Couarraze, G., Colombo, P., & Fattal, E. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00632-3 · Cited by 67
Absence of Toxicity of Chronic Weekly Intravenous Gene Therapy with Pegylated Immunoliposomes
Zhang, Y., Boado, R. J., & Pardridge, W. M. (2003) · Pharmaceutical Research · doi:10.1023/b:pham.0000003375.13655.f9 · Cited by 66
Schröeder, U., Schröeder, H., & Sabel, B. A. (2000) · Life Sciences · doi:10.1016/s0024-3205(99)00619-0 · Cited by 66
Niwa, T. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)00002-z · Cited by 64
Erosion of biodegradable block copolymers made of poly(d,l-lactic acid) and poly(ethylene glycol)
von Burkersroda, F., Gref, R., & Göpferich, A. M. (1997) · Biomaterials · doi:10.1016/s0142-9612(97)00098-7 · Cited by 63
Plard, J.-P., & Bazile, D. (1999) · Colloids and Surfaces B Biointerfaces · doi:10.1016/s0927-7765(99)00068-5 · Cited by 62
Waser, P. G., Müller, U., Kreuter, J., Berger, S., Munz, K., Kaiser, E., & Pfluger, B. (1987) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(87)90219-5 · Cited by 58
Onishi, H., Machida, Y., & Machida, Y. (2003) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.26.116 · Cited by 57
Teßmar, J., Mikos, A. G., & Göpferich, A. M. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00345-4 · Cited by 54
The effect of poly(ethylene glycol)–poly(d,l-lactic acid) diblock copolymers on peptide acylation
Lucke, A., Fustella, E., Teßmar, J., Gazzaniga, A., & Göpferich, A. M. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00020-2 · Cited by 53
Sahli, H., Tapon‐Bretaudière, J., Fischer, A., Sternberg, C., Spenlehauer, G., Verrecchia, T., & Labarre, D. (1997) · Biomaterials · doi:10.1016/s0142-9612(96)00146-9 · Cited by 52
Protein C-loaded monomethoxypoly (ethylene oxide)–poly(lactic acid) nanoparticles
Zambaux, M. F. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00548-2 · Cited by 51
Delié, F., Berton, M., Allémann, É., & Gurny, R. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00627-x · Cited by 51
Vidarabine-Loaded Nanoparticles: A Physicochemical Study
Guise, V., Drouin, J. Y., Benoit, J., Mahuteau, J., Dumont, P. A., & Couvreur, P. (1990) · Pharmaceutical Research · doi:10.1023/a:1015819706491 · Cited by 49
Lode, J., Fichtner, I., Kreuter, J., Berndt, A., Diederichs, J. E., & Reszka, R. C. (2001) · Pharmaceutical Research · doi:10.1023/a:1013094801351 · Cited by 47
Darius, J., Meyer, F. P., Sabel, B. A., & Schröeder, U. (2000) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357001774958 · Cited by 45
Chognot, D., Six, J., Léonard, M., Bonneaux, F., Vigneron, C., & Dellacherie, E. (2003) · Journal of Colloid and Interface Science · doi:10.1016/s0021-9797(03)00591-5 · Cited by 44
Emoto, K., Nagasaki, Y., Iijima, M., Kato, M., & Kataoka, K. (2000) · Colloids and Surfaces B Biointerfaces · doi:10.1016/s0927-7765(99)00159-9 · Cited by 43
Pharmacokinetics of [ 3 H]Biotin Bound to Different Avidin Analogues
Kang, Y., Saito, Y., & Pardridge, W. M. (1995) · Journal of drug targeting · doi:10.3109/10611869509059215 · Cited by 42
Zambaux, M. F., Faivre, B., Bonneaux, F., Marchal, S., Merlin, J., Dellacherie, E., Labrude, P., & Vigneron, C. (2000) · Biomaterials · doi:10.1016/s0142-9612(99)00233-1 · Cited by 41
Highly loaded nanoparticulate carrier using an hydrophobic antisense oligonucleotide complex
Berton, M., Allémann, É., Stein, C. A., & Gurny, R. (1999) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(99)00049-4 · Cited by 40
Pure antiestrogen RU 58668—loaded nanospheres: morphology, cell activity and toxicity studies
Ameller, T., Marsaud, V., Legrand, P., Gref, R., & Renoir, J. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2003.11.002 · Cited by 34
Stability of orosomucoid-coated polyisobutylcyanoacrylate nanoparticles in the presence of serum
Olivier, J., Vauthier, C., Taverna, M., Puisieux, F., Ferrier, D., & Couvreur, P. (1996) · Journal of Controlled Release · doi:10.1016/0168-3659(95)00175-1 · Cited by 33
Self-citationGref, R., Babak, V. G., Bouillot, P., Lukina, I., Bodorev, M., & Dellacherie, E. (1998) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/s0927-7757(98)00524-x · Cited by 32
Émile, C., Bazile, D., Herman, F., Hélène, C., & Veillard, M. (1996) · Drug Delivery · doi:10.3109/10717549609029449 · Cited by 29
Pharmacokinetics and Distribution of125I-PLA-b-PEO Block Copolymers in Rats
Novakova, K., Lázníček, M., Rypáček, F., & Machová, L. (2003) · Pharmaceutical Development and Technology · doi:10.1081/pdt-120018484 · Cited by 24
Heald, C. R., Stolnik, S., Matteis, C. D., Garnett, M. C., Illum, L., Davis, S. S., & Leermakers, F. A. M. (2002) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/s0927-7757(02)00292-3 · Cited by 9
Tissue distribution of polybutylcyanoacrylate nanoparticles carrying spin-labelled nitrosourea
Simeonova, M., Ivanova, T., Raikova, E., Georgieva, M., & Raikov, Z. (1988) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(88)90284-0 · Cited by 9
Cited by
Nanoparticle-based targeted drug delivery
Singh, R., & Lillard, J. W. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2008.12.004 · Cited by 2,734
Aggarwal, P., Hall, J. B., McLeland, C. B., Dobrovolskaia, M. A., & McNeil, S. E. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.009 · Cited by 1,791
Mohanraj, V. J., & Chen, Y. (2007) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v5i1.14634 · Cited by 1,217
Nanotechnology: Intelligent Design to Treat Complex Disease
Couvreur, P., & Vauthier, C. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0284-8 · Cited by 948
New emerging trends in synthetic biodegradable polymers—Polylactide: A critique
Gupta, A. P., & Kumar, V. (2007) · European Polymer Journal · doi:10.1016/j.eurpolymj.2007.06.045 · Cited by 941
Metadata
- Authors
- Olivier, J.-C.
- Venue
- NeuroRX
- Published
- 2005-01
- Volume
- 2
- Issue
- 1
- Pages
- 108-119
- ISSN
- 1545-5343 (ISSN-L)
- OpenAlex
- W2068491059
- Cited by
- 444
- References
- 150
- FWCI
- 7.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.